Safety testing of cosmetic product using Patch Test
- Conditions
- Skin irritation test
- Registration Number
- CTRI/2021/07/035262
- Lead Sponsor
- Entice Supplements Pvt Ltd
- Brief Summary
The patch test is the most common technique to evaluate a product tolerance on human skin. There are various methods of patch test which differ on the study objectives. The most common method is single application occlusive patch test for 24 hrs followed by observation after 48 hrs after application also. This method is a very common method in dermatological & inhalation practice to evaluate any intolerance which can result in acute dermatitis.
The current study objective isevaluation of dermatological safety and adverse reaction of Entice GlowMoisturizer for dermatological safety by 24 hrs patch test under completeocclusion on healthy human subjects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 24
- 1.Subjects in age group 18.
- 55 years (both the ages inclusive). 2.Healthy male & female subjects. 3.Subjects with Fitzpatrick skin type III to V. 4.Subjects willing to give a written informed consent. 5.Subjects willing to maintain the patch test in position for 24 hours. 6.Subject having not participated in a similar investigation in the past one month. 7.Subjects willing to come for regular follow up visits. 8.Subjects ready to follow instructions during the study period. Test period:9 days for all subjects including screening day.
- 1.Infection, allergy on the tested area.
- 2.Skin allergy, antecedents or atopic subjects.
- 3.Athletes and subjects with history of excessive sweating.
- 4.Cutaneous disease which may influence the study result.
- 5.Subjects on oral corticosteroid .
- 6.Subjects participating in any other cosmetic or therapeutic study.
- 7.Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The objective of this study is to evaluate the dermatological safety of the given investigational product/s on skin of healthy human volunteers by dermatological visual assessment 24 hrs
- Secondary Outcome Measures
Name Time Method Adverse event monitoring 0 hr to 24 hrs
Trial Locations
- Locations (1)
Sigma Skin & Cosmetology Clinic
🇮🇳Bangalore, KARNATAKA, India
Sigma Skin & Cosmetology Clinic🇮🇳Bangalore, KARNATAKA, IndiaDrMadan Mohan N TPrincipal investigator9845074316drmadan1969@gmail.com